Cole D E, Fukuda S, Gordon B A, Rip J W, LeCouteur A N, Rupar C A, Tomatsu S, Ogawa T, Sukegawa K, Orii T
Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.
Am J Med Genet. 1996 Jun 28;63(4):558-65. doi: 10.1002/(SICI)1096-8628(19960628)63:4<558::AID-AJMG9>3.0.CO;2-K.
Morquio disease (MPS IVA) is an autosomal recessive disorder caused by a deficiency of N-acetylgalactosamine-6-sulfate sulfatase (GALNS) activity. Patients commonly present in early infancy with growth failure, spondyloepiphyseal dysplasia, corneal opacification, and keratan sulfaturia, but milder forms have been described. We report on a patient who grew normally until age 5 years. Her keratan sulfaturia was not detected until adolescence, and she now has changes restricted largely to the axial skeleton. She has experienced only mildly impaired vision. At age 22, thin-layer chromatography of purified glycosaminoglycans showed some keratan sulfaturia. GALNS activity in fibroblast homogenate supernatants was 20 +/- 5% of controls (as compared to 5 +/- 3% of controls in severe MPS IVA, P < .003). Kinetic analysis of residual fibroblast GALNS activity in patient and parents revealed decreased K(m) and increased Vmax in the mother and daughter, but not in the father, compatible with compound heterozygosity. GALNS exons were amplified from patient genomic DNA and screened by SSCP. Two missense mutations, a C to T transition at position 335 (predicting R94C) and a T to G transversion at position 344 (predicting F97V), were found on sequencing an abnormally migrating exon 3 amplicon. Digestion of the amplicon with FokI and AccI restriction enzymes (specific for the R94C and F97V mutations, respectively) confirmed heterozygosity. In fibroblast transfection experiments, heterozygous R94C and F97V mutants independently expressed as severe and mild GALNS deficiency, respectively. We interpret these findings to indicate that our patient bears heteroallelic GALNS missense mutations, leading to GALNS deficiency and mild MPS IVA. Our findings expand the clinical and biochemical phenotype of MPS IVA, but full delineation of the genotype-phenotype relationship requires further study of native and transfected mutant cell lines.
黏多糖贮积症IV型(MPS IVA)是一种常染色体隐性疾病,由N - 乙酰半乳糖胺 - 6 - 硫酸酯酶(GALNS)活性缺乏引起。患者通常在婴儿早期出现生长发育迟缓、脊椎骨骺发育不良、角膜混浊和硫酸角质素尿症,但也有症状较轻的病例报道。我们报告了一名患者,她在5岁前生长发育正常。直到青春期才检测到她患有硫酸角质素尿症,目前她的病变主要局限于中轴骨骼。她仅经历了轻度视力受损。22岁时,纯化糖胺聚糖的薄层色谱显示存在一些硫酸角质素尿症。成纤维细胞匀浆上清液中的GALNS活性为对照的20±5%(严重MPS IVA患者为对照的5±3%,P <.003)。对患者及其父母的成纤维细胞GALNS活性进行动力学分析发现,母亲和女儿的K(m)降低而Vmax增加,父亲则无此现象,符合复合杂合性。从患者基因组DNA中扩增GALNS外显子并通过单链构象多态性(SSCP)进行筛查。对异常迁移的外显子3扩增子进行测序时,发现了两个错义突变,第335位的C到T转换(预测R94C)和第344位的T到G颠换(预测F97V)。用FokI和AccI限制性内切酶(分别对R94C和F97V突变具有特异性)消化扩增子证实了杂合性。在成纤维细胞转染实验中,杂合的R94C和F97V突变体分别独立表现为严重和轻度的GALNS缺乏。我们认为这些发现表明我们的患者携带杂合等位基因GALNS错义突变,导致GALNS缺乏和轻度MPS IVA。我们的发现扩展了MPS IVA的临床和生化表型,但要全面描述基因型与表型的关系还需要对天然和转染的突变细胞系进行进一步研究。